Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program

Medical Journal of Australia

Volumn 197, Issue 8, 2012, Pages 453-457

  Dey, Aditi ^a,b   Wang, Han ^a   Menzies, Robert ^a,b   Macartney, Kristine ^a,b  

^a NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; ADOLESCENT; ADULT; ANCESTRY GROUP; ARTICLE; AUSTRALIA; CHILD; COMPARATIVE STUDY; DISEASE SEVERITY; EVALUATION STUDY; HOSPITALIZATION; HUMAN; INCIDENCE; INDIGENOUS PEOPLE; MIDDLE AGED; NON INDIGENOUS PEOPLE; OUTCOME ASSESSMENT; PROGRAM EFFECTIVENESS; RETROSPECTIVE STUDY; TREATMENT FAILURE; VACCINATION; ABORIGINE; ETHNOLOGY; FEMALE; GASTROENTERITIS; HEALTH CARE QUALITY; INFANT; MALE; PRESCHOOL CHILD; ROTAVIRUS INFECTION; VIROLOGY;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; MALE; OCEANIC ANCESTRY GROUP; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; YOUNG ADULT;

EID: 84872618230     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.10062     Document Type: Article

References (26)

1. Parashar UD, Alexander JP, Glass RI. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2006; 55: 1-13.
2. Carlin JB, Chondros P, Masendycz P, et al. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-1996. Med J Aust 1998; 169: 252-256.
3. Chiu C, Dey A, Wang H, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell 2010; 34 Suppl: S1-S167.
4. Galati JC, Harsley S, Richmond P, Carlin JB. The burden of rotavirus-related illness among young children on the Australian health care system. Aust N Z J Public Health 2006; 30: 416-421.
5. Newall AT, MacIntyre CR, Wang H, et al. Burden of severe rotavirus disease in Australia. J Paediatr Child Health 2006; 42: 521-527.
6. Schultz R. Rotavirus gastroenteritis in the Northern Territory, 1995-2004. Med J Aust 2006; 185: 354-356.
7. Macartney KK, Burgess MA. Rapid impact of rotavirus vaccination in the United States: implications for Australia. Med J Aust 2009; 191: 131-132.
8. National Health and Medical Research Council. Australian immunisation handbook. 9th ed. Canberra: NHMRC, 2008.
9. Belshaw DA, Muscatello DJ, Ferson MJ, Nurkik A. Rotavirus vaccination one year on. Commun Dis Intell 2009; 33: 337-340.
10. Lambert SB, Faux CE, Hall L, et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust 2009; 191: 157-160.
11. Cook H, Krause V. A review of G2P[4] rotavirus outbreaks in Central Australia and how the introduction of Rotarix has affected the epidemiology. The Northern Territory Disease Control Bulletin 2010; 17: 14-21.
12. Buttery JP, Lambert SB, Grimwood K, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's national childhood vaccine schedule. Pediatr Infect Dis J 2011; 30: S25-S29.
13. Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine 2011; 29: 4663-4667.
14. Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126: e506-e512.
15. Macartney KK, Porwal M, Dalton D, et al. Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation program. J Paediatr Child Health 2011; 47: 266-270.
16. Snelling TL, Andrews RM, Kirkwood CD, et al. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in Central Australia. Clin Infect Dis 2011; 52: 191-199.
17. Snelling TL, Schultz R, Graham J, et al. Rotavirus and the Indigenous children of the Australian outback: monovalent vaccine effective in a highburden setting. Clin Infect Dis 2009; 49: 428-431.
18. Australian Institute of Health and Welfare. Indigenous identification in hospital separations data-quality report. Canberra: AIHW, 2010. (AIHW Cat. No. HSE 85; Health Services Series No. 35.)
19. Australian Bureau of Statistics. Australian Demographic Statistics. (ABS Cat. No. 3101.0.) http://www.abs.gov.au/ausstats/abs@.nsf/mf/ 3101.0/ (accessed Aug 2012).
20. Medicare Australia. Australian Childhood Immunisation Register. 2012. http://www. medicareaustralia.gov.au/public/services/acir/ index.jsp (accessed Mar 2012).
21. Hull B, Dey A, Mahajan D, et al. Immunisation coverage annual report, 2009. Commun Dis Intell 2011; 35: 132-148.
22. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22.
23. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33.
24. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204: 980-986.
25. Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect Dis 2004; 4: 91-99.
26. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362: 289-298.